Thermo Fisher Scientific

Thermo Fisher Scientific

Posted via Workday

Bilingual FSP Sn CRA - Oncology - Ontario/Quebec

Apply by Oct 28, 2026

Posted Oct 24, 2026

Role at a glance

Salary
Not yet verified Check the description for pay details; an amount or pay period has not been verified.
Location
Mississauga, Canada
Work arrangement
Hybrid
Employment
Full-time
Education
Must hold a Science based Bachelors Degree.

Spotted an issue?

We’ll check it against the original posting.

Log in to report

Role Summary

AI-generated

Senior Clinical Research Associate (CRA) role in oncology for Ontario/Quebec, listed as bilingual, with a standard Monday to Friday schedule in an office environment.

Generated from the employer's posting. Verify important details before applying.

View full posting

Qualifications

Science-based bachelor's degree and bilingual ability.

Required

  • Science based Bachelors Degree
  • Bilingual

Original job description

Content provided by the employer

Work Schedule

Standard (Mon-Fri)

Environmental Conditions

Office

Job Description

Bilingual FSP Sn CRA - Oncology - Ontario/Quebec. Must hold a Science based Bachelors Degree.

Compensation

The estimated annualized pay range for this position in Ontario is $98,000.00–$147,955.00.

Thermo Fisher Scientific

About the company

Thermo Fisher Scientific

Large Enterprise

Thermo Fisher Scientific is a global leader in serving science, providing a wide range of analytical instruments, reagents, and software solutions for healthcare, pharmaceuticals, and life sciences research. With a commitment to innovation and quality, the company enables customers to make significant advancements in scientific discovery and healthcare diagnostics. Thermo Fisher operates in more than 50 countries and employs over 80,000 people, fostering a collaborative environment aimed at enhancing global health and safety. Through its broad portfolio of brands and technologies, the company plays a vital role in accelerating life-changing research and improving patient outcomes worldwide.